Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends authorisation of first medicine specifically for irritable bowel syndrome 21 September 2012Press releaseHumanMedicines European Medicines Agency website unavailable intermittently Saturday 22 September 20 September 2012NewsCorporateMedicines World Alzheimer's Month: September 2012 20 September 2012NewsCorporate Merck KGaA withdraws its application for an extension of the indication for Erbitux (cetuximab) 19 September 2012Press releaseHuman Over 1000 SMEs now registered with European Medicines Agency SME office 18 September 2012Press releaseCorporateMedicinesSME Dr Tomas Salmonson elected new chair of the Committee for Medicinal Products for Human Use (CHMP) 17 September 2012NewsHuman European Medicines Agency seeks views on involvement of children and young people in Paediatric Committee 17 September 2012NewsHumanMedicinesPaediatrics Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 September 2012 14 September 2012Press releaseVeterinary RepliGen Europe Limited withdraws its marketing authorisation application for SecreFlo (secretin human) 14 September 2012Press releaseCorporate Committee for Orphan Medicinal Products elects new chair and vice-chair 13 September 2012NewsHumanRare diseases 1 … 244 245 246 247 248 Page 248 of 384 249 250 251 252 … 384
European Medicines Agency recommends authorisation of first medicine specifically for irritable bowel syndrome 21 September 2012Press releaseHumanMedicines
European Medicines Agency website unavailable intermittently Saturday 22 September 20 September 2012NewsCorporateMedicines
Merck KGaA withdraws its application for an extension of the indication for Erbitux (cetuximab) 19 September 2012Press releaseHuman
Over 1000 SMEs now registered with European Medicines Agency SME office 18 September 2012Press releaseCorporateMedicinesSME
Dr Tomas Salmonson elected new chair of the Committee for Medicinal Products for Human Use (CHMP) 17 September 2012NewsHuman
European Medicines Agency seeks views on involvement of children and young people in Paediatric Committee 17 September 2012NewsHumanMedicinesPaediatrics
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 September 2012 14 September 2012Press releaseVeterinary
RepliGen Europe Limited withdraws its marketing authorisation application for SecreFlo (secretin human) 14 September 2012Press releaseCorporate
Committee for Orphan Medicinal Products elects new chair and vice-chair 13 September 2012NewsHumanRare diseases